glp 1 blood brain barrier Frontiers Beyond diabetes and obesity: GLP‐1
Description
doi: 10.1111/ane.12793
Endocrinology, 152, 31033112
In hospitalized individuals with diabetes, does individualizing the timing and frequency of blood glucose monitoring based on nutritional intake and insulin administration, compared to using a standard monitoring schedule, improve inpatient clinical outcomes and treatment results
Verify current details directly with the platform before enrolling
Wennerlund J, Gunnarsson U, Strigrd K, Sundbom M
Rare Warning Signs When you begin treatment with a GLP-1 (glucagon-like peptide-1) receptor agonist, your body undergoes several metabolic changes
